Skip to main content

Nasdaq IPOs

DoorDash prices IPO at $102, well above the upwardly revised range

5 years 9 months ago
DoorDash, North America's largest online restaurant delivery service, raised $3.4 billion by offering 33 million shares at $102, well above the upwardly revised range of $90 to $95. The company had originally filed to offer the same number of shares at a range of $75-$85. At pric
Renaissance Capital

I, IPO: C3.ai brings artificial intelligence to Wall Street

5 years 9 months ago
Founded and led by Siebel Systems and Oracle alum Tom Siebel, C3.ai (AI) aims to apply predictive analytics to commercial industrial processes in the new software category of enterprise AI. Over the past decade, C3 has developed a suite of low-code/no-code software tools to rapid
Renaissance Capital

Life sciences SPAC Big Cypress Acquisition files for a $75 million IPO

5 years 9 months ago
Big Cypress Acquisition, a blank check company targeting life science businesses in the US and Israel, filed on Monday with the SEC to raise up to $75 million in an initial public offering. The Miami Beach, FL-based company plans to raise $75 million by offering 7.5 million unit
Renaissance Capital

Food Fight: How DoorDash stacks up against Just Eat Takeaway.com

5 years 9 months ago
The December unicorn IPO parade begins next week as DoorDash (DASH) prepares to raise $3.1 billion at a $35 billion valuation. Prospective investors will likely look to Europe's Just Eat Takeaway.com (ENXTAM: TKWY) as a top comp. DoorDash and Just Eat Takeaway.com are leader
Renaissance Capital

Bargain e-commerce platform Wish sets terms for $1.1 billion IPO

5 years 9 months ago
Wish, which provides an e-commerce platform for ultra-bargain unbranded merchandise, announced terms for its IPO on Monday. The San Francisco, CA-based company plans to raise $1.1 billion by offering 46 million shares at a price range of $22 to $24. At the midpoint of the propos
Renaissance Capital

AI drug discovery platform AbCellera sets terms for $357 million IPO

5 years 9 months ago
AbCellera Biologics, which provides an AI powered drug discovery platform for antibody therapies, announced terms for its IPO on Monday. The Vancouver, Canada-based company plans to raise $357 million by offering 23 million shares at a price range of $14 to $17. At the midpoint
Renaissance Capital
Checked
31 minutes 11 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed